Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Weir Group delivers 'strong' H1 performance

(Sharecast News) - Multinational engineering company Weir Group said on Thursday that it had delivered a "strong" H1 performance, with both revenue and profits improving. Weir said adjusted operating profits were up 17% to £237m, while margins climbed 220bps to 19.8%, driven by strong aftermarket demand and operational efficiency.

Orders rose 8% to £1.3bn, underpinned by brownfield momentum and a £40m tailings contract in Chile, with minerals growing 10%, while ESCO saw a 4% uptick, bolstered by Micromine's £12m contribution following its April acquisition.

Revenues were up 4% at £1.2bn on a constant currency basis, despite FX headwinds, while free operating cash conversion stood at 62%, with expectations to hit 90-100% by year-end.

Weir upgraded FY margin guidance to around 20%, citing continued strength in mining markets and progress on its Performance Excellence programme.

The FTSE 100-listed group also declared an interim dividend of 19.6p per share, up 9% year-on-year.

CEO Jon Stanton said: "Our strong performance in the first half of this year demonstrates our leadership in mining technology and the unique capabilities of our business model.

"Our businesses are focused, and with a continuous improvement mindset, driving excellent operational execution and mitigating any impacts of US tariffs."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.